[go: up one dir, main page]

Proskouriakoff, 1933 - Google Patents

Some Salts of Levulinic Acid1

Proskouriakoff, 1933

Document ID
7582750616674190194
Author
Proskouriakoff A
Publication year
Publication venue
Journal of the American Chemical Society

External Links

Snippet

By A. Proskouriakoff Introduction The therapeutic use of organic salts of metals depends considerably on the organic part of the molecule to which the metal is attached. This part affects the solubility of the salt, the stability and the Ph of its solu-tions and the reaction of the …
Continue reading at pubs.acs.org (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/06Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P-C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O-metal, -CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
US4267194A (en) Calcium derivatives of taurine having reinforced neuro-muscular activity
Harington Chemistry of thyroxine: isolation of thyroxine from the thyroid gland
Takamine Adrenalin the active principle of the suprarenal glands and its mode of preparation.
US4228099A (en) Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders
US4320146A (en) Treatment of hepatic and renal disorders with ornithine and arginine salts of branched chain keto acids
DE2508895A1 (en) SALT OF PHENYLALCANCARBONIC ACIDS WITH BASIC AMINO ACIDS
Proskouriakoff Some Salts of Levulinic Acid1
US4939164A (en) Strontium salt
JPS6133816B2 (en)
JPS6012347B2 (en) Production method of new amino acid derivatives
BG60797B2 (en) (1-Benzyl-1H-indazol-3-yl) OXYCETIC ACID WITH LYSINE AND A METHOD FOR PREPARING IT
JPS6131118B2 (en)
DE1806926A1 (en) Lithium salt of hydroquinone sulfonic acid
US2474989A (en) Injectable iron preparation and process for the manufacture of same
Selim et al. A new method for the direct isolation of glycine from protein hydrolysates
US3888990A (en) Medicaments containing epicatechin-2-sulfonic acids and salts thereof
RU2045268C1 (en) Antihistamine and antiallergic agent and method for preparing of glutaminate of hinuclidise-3-diphenylcarbinol as solution for injections
DE2408372C3 (en) Therapeutically acceptable salts of p-chlorohippuric acid and pharmaceutical preparations containing these or p-chlorohippuric acid
CN110684066B (en) The pharmaceutical preparation of citicoline and its new use for disturbance of consciousness in acute stage of cerebral infarction
FI63418B (en) FOERFARANDE FOER TILLVARATAGANDE AV REN KRISTALLIN BETA-AESKINUR FROEN AV HAESTKASTANJER
US3461211A (en) Lipotropic compositions and their administration
US2641609A (en) Therapeutic compound and method of preparing the same
KR830002843B1 (en) Method of preparation for alkyl-ketahexopy-randside derivaives
JPH05112463A (en) Therapeutic agent for cataract
SU659082A3 (en) Method of obtaining p-acetamidophenol diethylaminoacetate or its chlorine hydrate salt